| G45.02 | Arteria-vertebralis-Syndrom mit Basilaris-Symptomatik: Komplette Rückbildung innerhalb von 1 bis 24 Stunden |
|---|---|
| I10.0 | Benigne essentielle Hypertonie |
| ICD | Diagnosis |
|---|---|
| G45.02 | Arteria-vertebralis-Syndrom mit Basilaris-Symptomatik: Komplette Rückbildung innerhalb von 1 bis 24 Stunden |
| I10.0 | Benigne essentielle Hypertonie |
| PZN or GTIN | 7680627840086 |
|---|---|
| Vendor | Mepha Pharma AG |
| Drug | ASS CARDIO Mepha Filmtabl 100 mg |
| Ingestion amount | 1 - 0 - 1 - 0 |
| Ingestion unit | Pills |
| PZN or GTIN | 7680670740128 |
|---|---|
| Vendor | Mepha Pharma AG |
| Drug | EZETIMIB SIMVASTATIN Mepha Teva 10/20 mg |
| Ingestion amount | 0 - 0 - 20 - 0 |
| Ingestion unit | mg |
| PZN or GTIN | 7680658950051 |
|---|---|
| Vendor | Mepha Pharma AG |
| Drug | RAMIPRIL Mepha Tabl 5 mg |
| Ingestion amount | 0 - 1 - 0 - 0 |
| Ingestion unit | Pills |
| PZN-Code | Vendor | Drug | Ingestion amount | Ingestion unit |
|---|---|---|---|---|
| 7680627840086 | Mepha Pharma AG | ASS CARDIO Mepha Filmtabl 100 mg | 1 - 0 - 1 - 0 | Pills |
| 7680670740128 | Mepha Pharma AG | EZETIMIB SIMVASTATIN Mepha Teva 10/20 mg | 0 - 0 - 20 - 0 | mg |
| 7680658950051 | Mepha Pharma AG | RAMIPRIL Mepha Tabl 5 mg | 0 - 1 - 0 - 0 | Pills |
| Contact type | Person |
|---|---|
| Name | Wolfgang Retter |
| Date of birth | 13.06.1989 |
| Phone number | +41794467647 |
| testpatient@gmail.com |
| Contact type | Person |
|---|---|
| Name | Lisa Retter |
| Date of birth | 09.07.1985 |
| Phone number | +4915167348909 |
| testpatient@rettungsladen.de |
| Contact type | Person |
|---|---|
| Name | |
| Date of birth | - |
| Phone number | - |
| - |
| Contact type | Name | Date of birth | Phone number | |
|---|---|---|---|---|
| Person | Wolfgang Retter | 13.06.1989 | +41794467647 | testpatient@gmail.com |
| Person | Lisa Retter | 09.07.1985 | +4915167348909 | testpatient@rettungsladen.de |
| Person | - | - |
| Power of Attorney | |
|---|---|
| Custody Order | |
| Patient Decree | |
| Organ donation authorisation | - |